Home/Filings/4/0001214659-22-005990
4//SEC Filing

Horne William B. 4

Accession 0001214659-22-005990

CIK 0001677077other

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 5:01 PM ET

Size

9.9 KB

Accession

0001214659-22-005990

Insider Transaction Report

Form 4
Period: 2022-04-26
Transactions
  • Exercise/Conversion

    Common Stock

    2022-04-26$0.00/sh+250,000$100500,000 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2022-04-26250,0002,000,000 total
    Exercise: $0.00Exp: 2026-04-29Common Stock (250,000 underlying)
Holdings
  • Stock Options (Right to Buy)

    Exercise: $1.50Exp: 2029-11-25Common Stock (250,000 underlying)
    250,000
  • Stock Options (Right to Buy)

    Exercise: $1.50Exp: 2029-11-25Common Stock (250,000 underlying)
    250,000
Footnotes (4)
  • [F1]This transaction was effected pursuant to Rule 16b-3 with shares of common stock received upon the exercise of stock options.
  • [F2]The stock options exercised in this transaction were fully vested and exercisable as of the transaction date.
  • [F3]The stock options vest ratably over thirty-six (36) months beginning on the date of grant.
  • [F4]None of these performance-based stock options are vested or exercisable.

Issuer

Alzamend Neuro, Inc.

CIK 0001677077

Entity typeother

Related Parties

1
  • filerCIK 0001333268

Filing Metadata

Form type
4
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 5:01 PM ET
Size
9.9 KB